Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Raychaudhuri

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1995
CGS 26529: the biological profile of a novel, orally active 5-lipoxygenase inhibitor with an extended duration of actionE Kimble, T Kowalski, P Peters, et al.
Biochimica Et Biophysica Acta|April 15, 1988
Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo modelsE C Ku, A Raychaudhuri, G Ghai, et al.
Journal of Pharmacological and Toxicological Methods|November 1, 1993
LTB4-induced transient neutropenia in the rat: a model for evaluating efficacy and bioavailability of LTB4 receptor antagonistsT C Pellas, C Colombo, L R Fryer, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1997
Inhibition of LTB4 biosynthesis in situ by CGS 23885, a potent 5-lipoxygenase inhibitor, correlates with its pleural fluid concentrations in an experimentally induced rat pleurisy modelA Raychaudhuri, H Chertock, J Chovan, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1989
Characterization of CGS 8515 as a selective 5-lipoxygenase (5-LO) inhibitorE C Ku, A Raychaudhuri, G Ghai, et al.
Journal of Medicinal Chemistry|January 15, 1999
Carboxy-substituted cinnamides: a novel series of potent, orally active LTB4 receptor antagonistsP D Greenspan, R A Fujimoto, P J Marshall, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1995
CGS 26529: the biological profile of a novel, orally active 5-lipoxygenase inhibitor with an extended duration of actionE Kimble, T Kowalski, P Peters, et al.
Biochimica Et Biophysica Acta|April 15, 1988
Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo modelsE C Ku, A Raychaudhuri, G Ghai, et al.
Journal of Pharmacological and Toxicological Methods|November 1, 1993
LTB4-induced transient neutropenia in the rat: a model for evaluating efficacy and bioavailability of LTB4 receptor antagonistsT C Pellas, C Colombo, L R Fryer, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1997
Inhibition of LTB4 biosynthesis in situ by CGS 23885, a potent 5-lipoxygenase inhibitor, correlates with its pleural fluid concentrations in an experimentally induced rat pleurisy modelA Raychaudhuri, H Chertock, J Chovan, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1989
Characterization of CGS 8515 as a selective 5-lipoxygenase (5-LO) inhibitorE C Ku, A Raychaudhuri, G Ghai, et al.
Journal of Medicinal Chemistry|January 15, 1999
Carboxy-substituted cinnamides: a novel series of potent, orally active LTB4 receptor antagonistsP D Greenspan, R A Fujimoto, P J Marshall, et al.
Pageof 3